Skip to main content
Log in

Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics

  • Published:
European archives of psychiatry and neurological sciences Aims and scope Submit manuscript

Summary

Serum prolactin (PRL), luteinizing hormone (LH) and testosterone (T) levels were estimated in a group of 30 male paranoid schizophrenics before and after 4 weeks treatment with chlorpromazine and/or trihexyphenidyl, and in a group of 14 healthy male individuals. After treatment with chlorpromazine (100 mg t.i.d., p. o.), 10 patients presented a significant increase in serum PRL values and a significant decrease in serum T values. A significant increase in serum PRL values was also found in 10 patients who were treated with chlorpromazine (100 mg t.i.d., p. o.) plus trihexyphenidyl (5 mg t.i.d., p. o.). No significant difference in any of the investigated endocrine parameters was detected in 10 patients after 4 weeks administration of trihexyphenidyl (5mg t.i.d., p.o.). Following chlorpromazine treatment with or without concomitant administration of trihexyphenidyl, 20 patients showed a significant increase in serum PRL levels and a significant decrease in serum LH and T levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303–314

    Google Scholar 

  • Anden NE, Corrodi H, Fuxe K (1972) Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine-β-hydroxylase inhibitors. J Pharm Pharmacol 24:177–182

    Google Scholar 

  • Apter A, Dickerman Z, Gonen N, Assa S, Prager-Lewin R, Kaufman H, Tyano S, Laron Z (1983) Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys. Am J Psychiatry 140:1588–1591

    Google Scholar 

  • Benkert O, Klein HE, Hofschuster E, Seibold C (1981) Effect of the anticholinergic drug biperiden on pituitary hormones and cortisol. Psychoneuroendocrinology 6:231–238

    Google Scholar 

  • Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F (1975) Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia 44:17–22

    Google Scholar 

  • Cass Terry L, Crowley WR, Lynch C, Longserre C, Johnson MD (1982) Role of central epinephrine in regulation of anterior pituitary hormone secretion. Peptides 3:311–318

    Google Scholar 

  • Collu R, Jéquier JC, Leboeuf G, Letarte J, Ducharme JR (1975) Endocrine effects of pimozide, a specific dopaminergic blocker. J Clin Endocrinol Metab 41:981–984

    Google Scholar 

  • Davis BM, Brown GM, Miller M, Friesen HG, Kastin AJ, Davis KL (1982) Effects of cholinergic stimulation on pituitary hormone release. Psychoneuroendocrinology 7:347–354

    Google Scholar 

  • Davis JM, Vogel C, Gibbons R, Pavkovic I, Zhang M (1984) Pharmacoendocrinology of schizophrenia. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven, New York, pp 29–53

    Google Scholar 

  • DeRivera JL, Lal S, Ettigi P, Hontella S, Muller HF, Friesen HG (1976) Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol 5:273–282

    Google Scholar 

  • Drouva SV, Gallo RV (1976) Catecholamine involvement in episodic luteinizing hormone release in adult ovariectomized rats. Endocrinology 99:651–658

    Google Scholar 

  • Halbreich U, Sachar EJ, Nathan RS, Asnis GM, Halpern FS (1980) The effect of benztropine mesylate on the prolactin response to haloperidol. Psychopharmacology 72:61–65

    Google Scholar 

  • Hanlon TE, Schoenrich C, Freinek W, Turek I, Kurland AA (1966) Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients. Psychopharmacologia 9:328–339

    Google Scholar 

  • Kolakowska T, Wiles DH, Gelder MG, McNeilly AS (1976) Clinical significance of plasma chlorpromazine levels. Psychopharmacology 49:101–107

    Google Scholar 

  • Krawiecka M, Goldberg D, Vaughan M (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 55:299–308

    Google Scholar 

  • Krulich L (1979) Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Annu Rev Physiol 41:603–615

    Google Scholar 

  • Lal S, Mendis T, Cervantes P, Guyda H, DeRivera JL (1979) Effect of benztropine on haloperidol-induced prolactin secretion. Neuropsychobiology 5:327–331

    Google Scholar 

  • Martin JB, Reichlin S, Brown GM (1977) Neuroendocrinology of reproduction. In: Martin JB, Reichlin S, Brown GM (eds) Clinical neuroendocrinology. Davis, Philadelphia, pp 93–128

    Google Scholar 

  • Martin-DuPan R, Baumann P, Magrini G, Felber JP (1979) Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients. Psychoneuroendocrinology 3:245–252

    Google Scholar 

  • Meltzer HY (1984) Neuroendocrine abnormalities in schizophrenia: prolactin, growth hormone, and gonadotrophins. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology and psychiatric disorder. Raven, New York, pp 1–28

    Google Scholar 

  • Nakagawa K, Obara T, Matsubara M, Kubo M (1982) Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males. Clin Endocrinol 17:345–352

    Google Scholar 

  • Nathan RS, Asnis GM, Dyrenfurth I, Halpern FS, Halbreich U, Ostrow LC, Sachar EJ (1980) Plasma prolactin and testosterone during penfluridol treatment. Lancet II:94

    Google Scholar 

  • Praag HM van, Korf J (1975) Biochemical research into psychosis. Acta Psychiatr Scand 51:268–284

    Google Scholar 

  • Rivera-Calimlim L, Castaneda L, Lasagna L (1973) Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin Pharmacol Ther 14:978–986

    Google Scholar 

  • Rubin RT, Hays SE (1980) The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations. Psychoneuroendocrinology 5:121–137

    Google Scholar 

  • Rubinstein L, Sawyer CH (1970) Role of catecholamines in stimulating the release of pituitary ovulating hormones in rats. Endocrinology 86:988–995

    Google Scholar 

  • Singh MM, Kay SR (1979) Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Neuropsychobiology 5:74–86

    Google Scholar 

  • Siris SG, Siris ES, Kammen DP van, Docherty JP, Alexander PE, Bunney WE (1980) Effects of dopamine blockade on gonadotropins and testosterone in men. Am J Psychiatry 137:211–214

    Google Scholar 

  • Wode-Helgodt B, Eneroth P, Fyrö B, Gullberg B, Sedvall G (1977) Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Acta Psychiatr Scand 56:280–293

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rinieris, P., Hatzimanolis, J., Markianos, M. et al. Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics. Eur Arch Psychiatr Neurol Sci 237, 189–193 (1988). https://doi.org/10.1007/BF00449905

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00449905

Key words

Navigation